Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects
Public ClinicalTrials.gov record NCT00828204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study to Evaluate the Safe and Effective Use of the Single-Use Autoinjector With an Avonex® Prefilled Syringe in Multiple Sclerosis Subjects
Study identification
- NCT ID
- NCT00828204
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Interventions
- Avonex prefilled syringe via manual IM injection Device
- BG9418 (interferon beta-1a) Drug
- single-use autoinjector with a prefilled liquid Avonex syringe Device
Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Jun 30, 2010
- Completion
- Sep 30, 2010
- Last update posted
- Jun 2, 2014
2009 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Maitland | Florida | 32751 | — |
| Research Site | Atlanta | Georgia | 30327 | — |
| Fort Wayne Neurological Center | Fort Wayne | Indiana | 46804 | — |
| Research Site | Boston | Massachusetts | 2135 | — |
| Michigan Institute for Neurological Disorders | Farmington Hills | Michigan | 28595 | — |
| Research Site | Buffalo | New York | 14203 | — |
| Comprehensive Multiple Sclerosis Care Center | Patchogue | New York | 11772 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Neurology & Neuroscience Associates, Inc. | Akron | Ohio | 4320 | — |
| Research Site | Dallas | Texas | 75214 | — |
| Research Site | Round Rock | Texas | 78681 | — |
| Research Site | Salt Lake City | Utah | 84103 | — |
| Research Site | Richmond | Virginia | 23298 | — |
| Research Site | Charleston | West Virginia | 25301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00828204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2014 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00828204 live on ClinicalTrials.gov.